期刊文献+

Survivin和Livin在子宫内膜癌的表达及临床意义 被引量:2

EXPRESSIONS OF SURVIVIN AND LIVIN IN ENDOMETRIAL CANCER AND THEIR CLINICAL SIGNIFICANCE
下载PDF
导出
摘要 目的探讨Survivin和Livin在子宫内膜癌的表达及其临床意义。方法免疫组化法检测Survivin和Livin蛋白表达,分析其与子宫内膜癌临床病理特征之间的关系。结果 Survivin和Livin蛋白在子宫内膜癌的表达明显高于正常组织(P<0.05),蛋白表达与淋巴转移密切相关(P<0.05),与浸润深度、组织学分级及病理分期等无相关性(P>0.05)。结论 Survivin和Livin与子宫内膜癌的发生与转移密切相关,可作为肿瘤发展和预后评估的参考指标。 Objective To explore the expressions of survivin and livin protein in endometrial cancer tissues and their clinical significance.Methods Immunohistochemical method was used to detect the expressions of survivin and livin protein and to analyze the relationship between the expressions and pathological features of endometrial cancer.Results The expressions of survivin and livin protein in endometrial cancer tissues were significantly higher than those in normal tissues (P〈0.05).The protein expressions were closely related to lymphatic metastasis(P〈0.05).The protein expressions were not related to infiltration depth, histological grading and pathological staging(P〉0.05).Conclusion Survivin and Livin were closely related to the occurrence and metastasis of endometrial cancer and can be used as reference indicators of tumor development and prognosis evaluation.
作者 林诗莲
机构地区 沂南县人民医院
出处 《山东医学高等专科学校学报》 2017年第3期180-182,共3页 Journal of Shandong Medical College
关键词 子宫内膜癌 细胞凋亡 SURVIVIN LIVIN Endometrial cancer Apoptosis Survivin Livin
  • 相关文献

参考文献4

二级参考文献22

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1363
  • 2陈淼,陶晓南,张晓菊.凋亡抑制蛋白livin在非小细胞肺癌中的表达及临床意义[J].广东医学,2006,27(7):1014-1015. 被引量:5
  • 3黄青远,陈东义,赵志龙,崔肃,张林.Livin mRNA和Livin蛋白在食管癌组织中的表达[J].中国现代医学杂志,2007,17(3):298-300. 被引量:16
  • 4Bray F, Parkin DM, Evaluation of data quality in the cancer registry: Principles and methods. Part I : Comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45(5): 747-755.
  • 5Curado MP, Edwards B, Shin HR et al. Cancer incidence in five conti- nents, Vol. IX. IARC scientific publications No. 160[M]. Lyon: IARC, 2007.
  • 6Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IAtlC technical report No.19[M]. Lyon: IARC. 1994.
  • 7Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC technical report No.42[M]. Lyon: IARC, 2005.
  • 8Felay J. The IARCcrgTools program [CP/OL]. http://www.iaer.com.fr/iarc- crgtools.htm, 2006.
  • 9全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 10陈万青,张思维.中国肿瘤登记的代表性研究[J].中国肿瘤,2008,17(10):832-835. 被引量:12

共引文献337

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部